Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR18034 for postoperative analgesia after hemorrhoidectomy (Phase III)
ChiCTR2300070166Phase 3Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Apr 2023
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liposomal ropivacaine in postoperative pain (3 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: NRS pain intensity score. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
liposomal ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300070166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070166.